Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-7947
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKlein, Noreen-
dc.contributor.authorKümmerer, Nadine-
dc.contributor.authorHobernik, Dominika-
dc.contributor.authorSchneider, Dirk-
dc.date.accessioned2022-10-12T10:03:55Z-
dc.date.available2022-10-12T10:03:55Z-
dc.date.issued2015-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/7962-
dc.description.abstractSeveral point mutations have been identified in human aquaporins, but their effects on the function of the respective aquaporins are mostly enigmatic. We analyzed the impact of the aquaporin 2 mutation V71M, which causes nephrogenic diabetes insipidus in humans, on aquaporin structure and activity, using the bacterial aquaglyceroporin GlpF as a model. Importantly, the sequence and structure around the V71M mutation is highly conserved between aquaporin 2 and GlpF. The V71M mutation neither impairs substrate flux nor oligomerization of the aquaglyceroporin. Therefore, the human aquaporin 2 mutant V71M is most likely active, but cellular trafficking is probably impaired.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY-NC-ND*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.ddc500 Naturwissenschaftende_DE
dc.subject.ddc500 Natural sciences and mathematicsen_GB
dc.titleThe AQP2 mutation V71M causes nephrogenic diabetes insipidus in humans but does not impair the function of a bacterial homologen_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-7947-
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 09 Chemie, Pharmazie u. Geowissensch.de
jgu.organisation.number7950-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleFEBS Open Biode
jgu.journal.volume5de
jgu.pages.start640de
jgu.pages.end646de
jgu.publisher.year2015-
jgu.publisher.nameElsevier on behalf of the Federation of European Biochemical Societiesde
jgu.publisher.placeCambridgede
jgu.publisher.urihttp://dx.doi.org/10.1016/j.fob.2015.07.003de
jgu.publisher.issn2211-5463de
jgu.organisation.placeMainz-
jgu.subject.ddccode500de
opus.date.modified2018-09-05T09:10:39Z-
opus.subject.dfgcode00-000-
opus.organisation.stringFB 09: Chemie, Pharmazie und Geowissenschaften: Institut für Pharmaziede_DE
opus.identifier.opusid51959-
opus.institute.number0908-
opus.metadataonlyfalse-
opus.type.contenttypeKeinede_DE
opus.type.contenttypeNoneen_EN
opus.affiliatedSchneider, Dirk-
jgu.publisher.doi10.1016/j.fob.2015.07.003de
jgu.organisation.rorhttps://ror.org/023b0x485-
Appears in collections:DFG-OA-Publizieren (2012 - 2017)

Files in This Item:
  File Description SizeFormat
Thumbnail
the_aqp2_mutation_v71m_causes-20220925142606282.pdf1.55 MBAdobe PDFView/Open